News

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Pfizer's (NYSE:PFE) stock is up by a considerable 7.5% over the past month. However, we decided to pay attention to ...
Pfizer's dividend yield is around 7.3%, which is super generous. If you have an opening in your portfolio for a great stock ...
Although Pfizer has made some efforts to turn things around, they have been insufficient. Pfizer's poor performance since 2022 is largely due to its coronavirus portfolio.
Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...
Keep in mind, though, that investors have been dumping Pfizer stock since 2022. If a company holds its dividend steady when the stock price tanks, as Pfizer has done, dividend yields will soar.
The stock jumped 11.91% during the day to touch a high of Rs 4,995.85 on the stock exchanges, after starting the day at Rs 4,698.80.
BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...
(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...
Pfizer (PFE) has been one of the most searched ... between trends in earnings estimate revisions and near-term stock price movements. Powered by Money.com - Yahoo may earn commission from the ...